This article was originally published in The Tan Sheet
Pharmaca Integrative Pharmacy announces removal of dietary supplements containing bovine-derived brain, skull, eye and nerve materials from shelves Feb. 24 as a result of bovine spongiform encephalopathy (BSE, or mad cow disease) safety concerns. Removal affects six "hormonal cognitive and support" products primarily sold to naturopathic practitioners. Pharmaca's action follows FDA's recent announcement of intention to ban a range of bovine-derived materials from food products, including dietary supplements (1"The Tan Sheet" Feb. 2, 2004, p. 9)...
You may also be interested in...
FDA and HHS will publish two interim final rules intended to ban certain bovine-derived materials from food products, including dietary supplements, in order to prevent the spread of bovine spongiform encephalopathy (BSE, also known as "mad cow disease")
Just five weeks before the US election, a Medtech Insight analysis shows medical device companies are spending more on Democrat Joe Biden’s campaign than on Republican Donald Trump’s.
Denmark’s Orphazyme has raised more funds to market its lead product, the heat shock protein amplifier, arimoclomol, in the US and Europe, and to evaluate the compound for other lysosomal storage and neurodegenerative disorders.